Brief: Cumberland Pharmaceuticals - Expects Caldolor Injection Product As Eligible For Special Medicare Reimbursement

Cumberland Pharmaceuticals

17/04/2023 12:01

April 17 (Reuters) - Cumberland Pharmaceuticals Inc
 CPIX.O :
    * CUMBERLAND PHARMACEUTICALS -  ON APRIL 14, ANNOUNCED IT
EXPECTS
THAT CALDOLOR INJECTION PRODUCT SHOULD BE ELIGIBLE FOR SPECIAL
MEDICARE REIMBURSEMENT
    * CUMBERLAND PHARMACEUTICALS INC - EXPECTS THAT NOPAIN ACT
WILL
AFFECT MEDICARE REIMBURSEMENT FOR CALDOLOR
    * CUMBERLAND PHARMA -METHODOLOGY FOR REIMBURSEMENT FOR
NON-OPIOID
PAIN ALTERNATIVES TO APPLY TO PRODUCTS FURNISHED BETWEEN JAN 1,
2025 & JAN 1, 2028

Source text for Eikon: [ID:https://t.ly/ivUU]
Further company coverage:  CPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))